Anthony Gregg Lapointe

Insider Reports History

Location
Po Box 83216, Gaithersburg, MD
Signature
/s/ Gregg A. Lapointe
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Anthony Gregg Lapointe:

Stock Role Class Num Shares Value Price $ Report Date Ownership
RIGEL PHARMACEUTICALS INC Director Common Stock 12.5K $238K $19.06 May 23, 2025 Direct
Astria Therapeutics, Inc. Director Stock Option (Right to Buy) 26.6K Jun 11, 2025 Direct
SOLIGENIX, INC. Director Stock Option (Right to Buy) 17.6K Jun 20, 2025 Direct
RIGEL PHARMACEUTICALS INC Director Stock Option (Right to Buy) 3K May 23, 2025 Direct

Insider Reports Filed by Anthony Gregg Lapointe

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SNGX SOLIGENIX, INC. Jun 20, 2025 1 $0 4 Jun 20, 2025 Director
ATXS Astria Therapeutics, Inc. Jun 11, 2025 1 $0 4 Jun 12, 2025 Director
RIGL RIGEL PHARMACEUTICALS INC May 23, 2025 2 $0 4 May 28, 2025 Director
SNGX SOLIGENIX, INC. Dec 12, 2024 1 $0 4 Dec 13, 2024 Director
ATXS Astria Therapeutics, Inc. Jun 5, 2024 1 $0 4 Jun 6, 2024 Director
RIGL RIGEL PHARMACEUTICALS INC May 25, 2024 2 $0 4 May 29, 2024 Director
SNGX SOLIGENIX, INC. Dec 15, 2023 1 $0 4 Dec 15, 2023 Director
ATXS Astria Therapeutics, Inc. Jun 2, 2023 1 $0 4 Jun 6, 2023 Director
RIGL RIGEL PHARMACEUTICALS INC May 26, 2023 2 $0 4 Jul 12, 2023 Director
SNGX SOLIGENIX, INC. Nov 17, 2022 1 $0 4 Nov 21, 2022 Director
ATXS Astria Therapeutics, Inc. Jun 9, 2022 1 $0 4/A Jun 21, 2022 Director
RIGL RIGEL PHARMACEUTICALS INC May 20, 2022 2 $0 4 May 23, 2022 Director
SNGX SOLIGENIX, INC. Sep 23, 2021 1 $0 4 Sep 24, 2021 Director
ATXS CATABASIS PHARMACEUTICALS INC Jun 2, 2021 1 $0 4 Jun 2, 2021 Director
RIGL RIGEL PHARMACEUTICALS INC May 19, 2021 2 $0 4 May 21, 2021 Director